Focusing on Fluoride: From FDA To Class Action

The U.S. Food and Drug Administration announced that it is convening a public meeting "to seek public input on the clinical use and safety concerns associated with the use of orally ingestible unapproved prescription drug products containing fluoride in the pediatric population." Of counsel Rachel Turow discusses the FDA's recent efforts to remove such fluoride products from the market, the legal actions taken against fluoride products and the broader context of fluoride safety concerns.